ARS Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment in USD from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2020 to Q1 2025.
  • ARS Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $91K, a 9.64% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $563K, a 222% increase from 2023.
  • ARS Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $175K, a 12.1% decline from 2022.
  • ARS Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $199K, a 262% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

ARS Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $91K +$8K +9.64% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 $83K -$110K -57% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $193K +$172K +819% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $21K -$14K -40% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $35K +$2K +6.06% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $33K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13

ARS Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $563K +$388K +222% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $175K -$24K -12.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $199K +$144K +262% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $55K -$862K -94% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $917K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.